Skip to content
Research Article Open access CC BY 3.0

Use of DonnatalTM Elixir in the Treatment of Neonatal Abstinence Syndrome

Alyssa Brzenski, Mark Greenberg

Journal of Advances in Medicine and Medical Research · pp. 5446–5450 · Published 29 Jul 2014

10.9734/BJMMR/2014/12419

Abstract

We present the case of a 6-week-old male infant with Neonatal Abstinence Syndrome (NAS) in which DonnatalTM (phenobarbital, hyoscyamine, atropine, hyoscine) Elixir was used as an adjunct therapy. The infant was born to a mother taking 130mg of methadone per day since conception. Due to NAS, he was treated with a methadone taper and oral clonidine. Yet, despite the majority of symptoms being suppressed with these medications, he remained stricken with colicky pain, unresponsive to supplemental opioids. A trial of DonnatalTM resulted in relief of symptoms and completion of his opioid taper. We recommend DonnatalTM as part of the treatment plan for refractory abdominal symptoms in cases of NAS.

DonnatalTM belladonna alkaloids withdrawal colic neonatal abstinence syndrome visceral abdominal pain.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.